DK1749031T3 - Anvendelse af en scFv til reduktion af eksisterende biofilm - Google Patents
Anvendelse af en scFv til reduktion af eksisterende biofilmInfo
- Publication number
- DK1749031T3 DK1749031T3 DK05748130.1T DK05748130T DK1749031T3 DK 1749031 T3 DK1749031 T3 DK 1749031T3 DK 05748130 T DK05748130 T DK 05748130T DK 1749031 T3 DK1749031 T3 DK 1749031T3
- Authority
- DK
- Denmark
- Prior art keywords
- scfv
- reduce existing
- existing biofilms
- biofilms
- reduce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0410958.3A GB0410958D0 (en) | 2004-05-15 | 2004-05-15 | Methods for reducing biofilm formation in infectious bacteria |
PCT/GB2005/001843 WO2005111080A2 (en) | 2004-05-15 | 2005-05-13 | Methods for reducing biofilm formation in infectious bacteria |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1749031T3 true DK1749031T3 (da) | 2013-09-23 |
Family
ID=32527168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05748130.1T DK1749031T3 (da) | 2004-05-15 | 2005-05-13 | Anvendelse af en scFv til reduktion af eksisterende biofilm |
Country Status (12)
Country | Link |
---|---|
US (1) | US20090117109A1 (da) |
EP (2) | EP1749031B1 (da) |
JP (2) | JP2008502710A (da) |
KR (2) | KR20130036365A (da) |
CN (1) | CN1984929A (da) |
AU (1) | AU2005243459B2 (da) |
CA (1) | CA2566588A1 (da) |
DK (1) | DK1749031T3 (da) |
ES (1) | ES2427933T3 (da) |
GB (1) | GB0410958D0 (da) |
NO (1) | NO20065671L (da) |
WO (1) | WO2005111080A2 (da) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2100602A1 (en) * | 2008-03-12 | 2009-09-16 | QuoNova Europe GmbH | Method and compositions suitable for treatment of wounds |
KR100868574B1 (ko) * | 2008-03-17 | 2008-11-13 | 한국광해관리공단 | 토양 입자 표면에 형성된 바이오필름의 함량 측정 방법 |
CN102388064A (zh) * | 2009-03-27 | 2012-03-21 | 高裘企业公司 | 用于筛选与使用拮抗孢子-表面交互作用的化合物的组合物与方法 |
US20120097606A1 (en) * | 2009-06-22 | 2012-04-26 | Sumitomo Heavy Industries, Ltd. | Method for treating wastewater containing ammonia nitrogen |
WO2012058531A2 (en) * | 2010-10-29 | 2012-05-03 | North Carolina State University | Modulation of response regulators by imidazole derivatives |
EP2655402A1 (en) * | 2010-12-23 | 2013-10-30 | Intercell Austria AG | Oprf/i agents and their use in hospitalized and other patients |
JP2014506923A (ja) | 2011-03-01 | 2014-03-20 | クオラム イノベーションズ リミテッド ライアビリティ カンパニー | 病原性バイオフィルムと関連した状態を治療するための物質および方法 |
US9387189B2 (en) | 2013-05-22 | 2016-07-12 | Professional Compounding Centers Of America (Pcca) | Antibiotic composition comprising a chemotactic agent and a nutrient dispersion |
NO342374B1 (en) * | 2016-07-08 | 2018-05-14 | Inhibio As | Compounds and compositions for biofilm prevention |
KR102305308B1 (ko) * | 2019-06-12 | 2021-09-27 | 서정옥 | 좌석용 헤드레스트 목베개 |
US20240123101A1 (en) * | 2022-10-13 | 2024-04-18 | Hossam Abdel Salam El Sayed Mohamed | System and method for prevention of corrosive biofilm formation in petroleum holding or carrying structures |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5254671A (en) * | 1990-04-27 | 1993-10-19 | Tanox Biosystems, Inc. | Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
AU753329C (en) * | 1997-06-18 | 2003-05-15 | Montana State University | Homoserine lactones biofilm regulating compounds and their methods of use |
US6395282B1 (en) * | 1998-04-16 | 2002-05-28 | University Of Rochester | Immunogenic conjugates of Gram-negative bacterial autoinducer molecules |
WO1999061021A1 (fr) * | 1998-05-26 | 1999-12-02 | Shionogi & Co., Ltd. | Agents de recouvrement de sensibilite aux medicaments destines a des micro-organismes pathogenes resistants |
US6090388A (en) * | 1998-06-20 | 2000-07-18 | United Biomedical Inc. | Peptide composition for prevention and treatment of HIV infection and immune disorders |
AU3580800A (en) | 1998-11-25 | 2000-06-26 | Mcw Research Foundation, Inc. | Method of and compositions for immunization with the (pseudomonas) v antigen |
GB9924195D0 (en) | 1999-10-13 | 1999-12-15 | Univ Nottingham | N-Acyl homoserine lactones for the treatment of cardiac tachyarrhythmias Ischaemic heart disease or congestive heart failure |
GB0007588D0 (en) | 2000-03-30 | 2000-05-17 | Univ Nottingham | N-Acyl homoserine lactones |
US6703513B1 (en) * | 2000-06-02 | 2004-03-09 | K-Quay Enterprises Llc | Production and use of derivatized homoserine lactones |
EP1528935B1 (en) * | 2002-08-13 | 2012-03-21 | Haptogen Ltd | Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody |
GB0407008D0 (en) * | 2004-03-27 | 2004-04-28 | Haptogen Ltd | Methods for inducing rapid cell death (autolysis) in infectious bacteria |
-
2004
- 2004-05-15 GB GBGB0410958.3A patent/GB0410958D0/en not_active Ceased
-
2005
- 2005-05-13 EP EP05748130.1A patent/EP1749031B1/en not_active Not-in-force
- 2005-05-13 US US11/568,673 patent/US20090117109A1/en not_active Abandoned
- 2005-05-13 CA CA002566588A patent/CA2566588A1/en not_active Abandoned
- 2005-05-13 AU AU2005243459A patent/AU2005243459B2/en not_active Ceased
- 2005-05-13 WO PCT/GB2005/001843 patent/WO2005111080A2/en active Application Filing
- 2005-05-13 EP EP10182405A patent/EP2281839A3/en not_active Withdrawn
- 2005-05-13 KR KR1020137005162A patent/KR20130036365A/ko not_active Application Discontinuation
- 2005-05-13 KR KR1020067026346A patent/KR20070038464A/ko active Search and Examination
- 2005-05-13 JP JP2007517401A patent/JP2008502710A/ja active Pending
- 2005-05-13 CN CNA2005800231734A patent/CN1984929A/zh active Pending
- 2005-05-13 ES ES05748130T patent/ES2427933T3/es active Active
- 2005-05-13 DK DK05748130.1T patent/DK1749031T3/da active
-
2006
- 2006-12-08 NO NO20065671A patent/NO20065671L/no unknown
-
2010
- 2010-08-25 JP JP2010187843A patent/JP2011042651A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
NO20065671L (no) | 2006-12-08 |
EP1749031B1 (en) | 2013-07-17 |
EP2281839A2 (en) | 2011-02-09 |
KR20130036365A (ko) | 2013-04-11 |
AU2005243459B2 (en) | 2011-11-03 |
WO2005111080A3 (en) | 2006-01-12 |
EP1749031A2 (en) | 2007-02-07 |
JP2008502710A (ja) | 2008-01-31 |
EP2281839A3 (en) | 2013-02-27 |
AU2005243459A1 (en) | 2005-11-24 |
WO2005111080A2 (en) | 2005-11-24 |
ES2427933T3 (es) | 2013-11-04 |
US20090117109A1 (en) | 2009-05-07 |
GB0410958D0 (en) | 2004-06-16 |
KR20070038464A (ko) | 2007-04-10 |
JP2011042651A (ja) | 2011-03-03 |
CN1984929A (zh) | 2007-06-20 |
AU2005243459A2 (en) | 2005-11-24 |
CA2566588A1 (en) | 2005-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1749031T3 (da) | Anvendelse af en scFv til reduktion af eksisterende biofilm | |
DK1778618T3 (da) | Syntese af triethylentetraminer | |
DK2015754T3 (da) | Anvendelse af dpp-iv-inhibitorer | |
DK2317851T3 (da) | Anvendelse af 5-fluorcytosin som fungicid | |
DK1802872T3 (da) | Rörledning | |
DK2024504T4 (da) | Fremstilling af isoprenoider | |
DK3225251T3 (da) | Modulering af pro-neurotrofinaktivitet | |
ATE456276T1 (de) | Verwendung dekrementeller zuweisungen | |
DK1931350T3 (da) | Administration af inhibitorer af dipeptidylpeptidase | |
DK2031063T3 (da) | Modulatorer af duftreceptorer | |
DK1763520T3 (da) | Anvendelse af trisubstituerede benzopyranoner | |
DK1951636T3 (da) | Fremstilling af cementholdig plade | |
DK3208269T3 (da) | Inhibitorer af c-fms-kinase | |
DK1898903T3 (da) | Inhibitorer af Akt-aktivitet | |
DK2700786T3 (da) | Modifikation af overførselspassage | |
DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
DK1720866T3 (da) | Fremgangsmåde | |
DK2117523T3 (da) | Inhibitorer af AKT-aktivitet | |
DK1979314T3 (da) | Indolsulfonamidmodulatorer af progesteronreceptorer | |
DK2371818T3 (da) | Hydroxybenzoatsalte af metanikotinforbindelser | |
DK1874766T3 (da) | Krystallinsk form af en quinolinon-carboxamid-forbindelse | |
DK2111555T3 (da) | Diagnosticering af præeklampsi | |
DK1940465T3 (da) | Ny anvendelse af anti-IL-1beta-antistoffer | |
DK2350116T3 (da) | Behandling af biofilm | |
DK2153565T3 (da) | Valg af transmissionsmodus |